Literature DB >> 24850736

A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.

Stelios Tzellos1, Paulo B Correia1, Claudio Elgueta Karstegl1, Laila Cancian1, Julian Cano-Flanagan2, Michael J McClellan2, Michelle J West2, Paul J Farrell3.   

Abstract

UNLABELLED: Sequence differences in the EBNA-2 protein mediate the superior ability of type 1 Epstein-Barr virus (EBV) to transform human B cells into lymphoblastoid cell lines compared to that of type 2 EBV. Here we show that changing a single amino acid (S442D) from serine in type 2 EBNA-2 to the aspartate found in type 1 EBNA-2 confers a type 1 growth phenotype in a lymphoblastoid cell line growth maintenance assay. This amino acid lies in the transactivation domain of EBNA-2, and the S442D change increases activity in a transactivation domain assay. The superior growth properties of type 1 EBNA-2 correlate with the greater induction of EBV LMP-1 and about 10 cell genes, including CXCR7. In chromatin immunoprecipitation assays, type 1 EBNA-2 is shown to associate more strongly with EBNA-2 binding sites near the LMP-1 and CXCR7 genes. Unbiased motif searching of the EBNA-2 binding regions of the differentially regulated cell genes identified an ETS-interferon regulatory factor composite element motif that closely corresponds to the sequences known to mediate EBNA-2 regulation of the LMP-1 promoter. It appears that the superior induction by type 1 EBNA-2 of the cell genes contributing to cell growth is due to their being regulated in a manner different from that for most EBNA-2-responsive genes and in a way similar to that for the LMP-1 gene. IMPORTANCE: The EBNA-2 transcription factor plays a key role in B cell transformation by EBV and defines the two EBV types. Here we identify a single amino acid (Ser in type 1 EBV, Asp in type 2 EBV) of EBNA-2 that determines the superior ability of type 1 EBNA-2 to induce a key group of cell genes and the EBV LMP-1 gene, which mediate the growth advantage of B cells infected with type 1 EBV. The EBNA-2 binding sites in these cell genes have a sequence motif similar to the sequence known to mediate regulation of the EBV LMP-1 promoter. Further detailed analysis of transactivation and promoter binding provides new insight into the physiological regulation of cell genes by EBNA-2.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850736      PMCID: PMC4136291          DOI: 10.1128/JVI.01000-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5.

Authors:  S J Bark-Jones; H M Webb; M J West
Journal:  Oncogene       Date:  2006-03-16       Impact factor: 9.867

2.  An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.

Authors:  J I Cohen; E Kieff
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.

Authors:  A Sjöblom; A Jansson; W Yang; S Laín; T Nilsson; L Rymo
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

4.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 5.  Deciphering cis-regulatory control in inflammatory cells.

Authors:  Serena Ghisletti; Gioacchino Natoli
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-05-06       Impact factor: 6.237

6.  Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells.

Authors:  Lindsay C Spender; Walter Lucchesi; Gustavo Bodelon; Antonio Bilancio; Claudio Elgueta Karstegl; Tomoichiro Asano; Oliver Dittrich-Breiholz; Michael Kracht; Bart Vanhaesebroeck; Paul J Farrell
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

7.  An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.

Authors:  A Sjöblom; W Yang; L Palmqvist; A Jansson; L Rymo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 8.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.

Authors:  Thomas Gaj; Charles A Gersbach; Carlos F Barbas
Journal:  Trends Biotechnol       Date:  2013-05-09       Impact factor: 19.536

9.  C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.

Authors:  Laila Cancian; Rachel Bosshard; Walter Lucchesi; Claudio Elgueta Karstegl; Paul J Farrell
Journal:  PLoS Pathog       Date:  2011-07-28       Impact factor: 6.823

10.  Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.

Authors:  Philippe R Chabot; Luca Raiola; Mathieu Lussier-Price; Thomas Morse; Genevieve Arseneault; Jacques Archambault; James G Omichinski
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

View more
  27 in total

1.  Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.

Authors:  Laura R Wasil; Kathy H Y Shair
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  Epstein-Barr virus genetic variants are associated with multiple sclerosis.

Authors:  Rosella Mechelli; Caterina Manzari; Claudia Policano; Anita Annese; Ernesto Picardi; Renato Umeton; Arianna Fornasiero; Anna Maria D'Erchia; Maria Chiara Buscarinu; Cristina Agliardi; Viviana Annibali; Barbara Serafini; Barbara Rosicarelli; Silvia Romano; Daniela F Angelini; Vito A G Ricigliano; Fabio Buttari; Luca Battistini; Diego Centonze; Franca R Guerini; Sandra D'Alfonso; Graziano Pesole; Marco Salvetti; Giovanni Ristori
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

3.  Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.

Authors:  Anqi Wang; Rene Welch; Bo Zhao; Tram Ta; Sündüz Keleş; Eric Johannsen
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children.

Authors:  Carrie B Coleman; Ibrahim I Daud; Sidney O Ogolla; Julie A Ritchie; Nicholas A Smith; Peter O Sumba; Arlene E Dent; Rosemary Rochford
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

Review 5.  Epstein-Barr virus: Biology and clinical disease.

Authors:  Blossom Damania; Shannon C Kenney; Nancy Raab-Traub
Journal:  Cell       Date:  2022-09-15       Impact factor: 66.850

6.  The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.

Authors:  Anders Friberg; Sybille Thumann; Janosch Hennig; Peijian Zou; Elfriede Nössner; Paul D Ling; Michael Sattler; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2015-05-29       Impact factor: 6.823

7.  Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.

Authors:  Anne L Palser; Nicholas E Grayson; Robert E White; Craig Corton; Samantha Correia; Mohammed M Ba Abdullah; Simon J Watson; Matthew Cotten; John R Arrand; Paul G Murray; Martin J Allday; Alan B Rickinson; Lawrence S Young; Paul J Farrell; Paul Kellam
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

8.  EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1.

Authors:  Fang Lu; Horng-Shen Chen; Andrew V Kossenkov; Karen DeWispeleare; Kyoung-Jae Won; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2016-01-11       Impact factor: 6.823

Review 9.  Epstein-Barr Virus: Diseases Linked to Infection and Transformation.

Authors:  Hem C Jha; Yonggang Pei; Erle S Robertson
Journal:  Front Microbiol       Date:  2016-10-25       Impact factor: 5.640

10.  RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.

Authors:  Andrea Gunnell; Helen M Webb; C David Wood; Michael J McClellan; Billy Wichaidit; Bettina Kempkes; Richard G Jenner; Cameron Osborne; Paul J Farrell; Michelle J West
Journal:  Nucleic Acids Res       Date:  2016-02-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.